Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,648 INR | +0.78% | +2.58% | +2.72% |
May. 14 | Nomura Upgrades Dr. Lal Pathlabs to Buy From Neutral, Adjusts Price Target to INR2,713 From INR2,505 | MT |
May. 13 | Dr. Lal Pathlabs' Fiscal Q4 Consolidated Net Profit Rises; Share Up 6% | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.72% | 2.62B | |
-24.16% | 7.66B | |
+68.13% | 4.35B | |
-2.98% | 2.53B | |
-46.17% | 2.21B | |
-15.51% | 1.79B | |
-23.12% | 1.48B | |
+13.62% | 1.18B | |
-43.81% | 1.13B | |
+20.41% | 997M |
- Stock Market
- Equities
- LALPATHLAB Stock
- News Dr. Lal PathLabs Limited
- Transcript : Dr. Lal PathLabs Limited, Q4 2024 Earnings Call, May 10, 2024